Smith & Nephew SNATS - 26 Year Stock Price History | SNN
Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits and dividends. The latest closing stock price for Smith & Nephew SNATS as of July 28, 2025 is 31.18.
- The all-time high Smith & Nephew SNATS stock closing price was 44.77 on February 20, 2020.
- The Smith & Nephew SNATS 52-week high stock price is 31.84, which is 2.1% above the current share price.
- The Smith & Nephew SNATS 52-week low stock price is 23.69, which is 24% below the current share price.
- The average Smith & Nephew SNATS stock price for the last 52 weeks is 28.01.
| Smith & Nephew SNATS Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 27.7043 | 24.0032 | 31.8400 | 23.5015 | 31.1800 | 28.95% |
| 2024 | 26.3898 | 25.6683 | 30.8279 | 23.1599 | 24.1803 | -7.28% |
| 2023 | 26.4463 | 25.3432 | 30.8819 | 20.6016 | 26.0794 | 4.44% |
| 2022 | 26.3838 | 31.7446 | 32.8835 | 20.1247 | 24.9717 | -20.20% |
| 2021 | 35.1361 | 38.0542 | 40.6313 | 28.9064 | 31.2926 | -16.21% |
| 2020 | 35.9028 | 41.8529 | 44.7749 | 24.0869 | 37.3458 | -10.40% |
| 2019 | 36.8331 | 31.0193 | 42.0523 | 30.2609 | 41.6795 | 30.84% |
| 2018 | 30.6991 | 29.1602 | 33.3558 | 27.6106 | 31.8545 | 8.90% |
| 2017 | 28.2871 | 24.5971 | 32.1681 | 24.5233 | 29.2521 | 18.57% |
| 2016 | 26.3231 | 28.0198 | 28.5409 | 22.2350 | 24.6710 | -13.93% |
| 2015 | 27.9615 | 28.4466 | 30.2158 | 26.1518 | 28.6639 | -1.40% |
| 2014 | 25.8157 | 22.0072 | 30.5712 | 22.0072 | 29.0717 | 30.44% |
| 2013 | 18.4620 | 16.9194 | 22.3210 | 16.0602 | 22.2868 | 32.51% |
| 2012 | 15.2527 | 14.5455 | 16.8981 | 13.5578 | 16.8192 | 17.41% |
| 2011 | 15.1556 | 15.3992 | 17.6212 | 12.4547 | 14.3254 | -6.88% |
| 2010 | 13.8901 | 14.8886 | 15.5547 | 12.0071 | 15.3845 | 4.10% |
| 2009 | 11.3592 | 9.2315 | 14.8165 | 8.6567 | 14.7790 | 61.58% |
| 2008 | 15.2477 | 16.1432 | 19.2076 | 8.6057 | 9.1466 | -43.13% |
| 2007 | 16.8137 | 14.5387 | 18.9835 | 14.4555 | 16.0843 | 10.72% |
| 2006 | 12.3007 | 13.0037 | 14.6165 | 10.2125 | 14.5276 | 14.15% |
| 2005 | 13.1049 | 13.8114 | 14.3583 | 11.0543 | 12.7264 | -9.51% |
| 2004 | 13.2870 | 11.2625 | 15.6986 | 10.9825 | 14.0641 | 24.64% |
| 2003 | 8.8525 | 8.2202 | 11.3863 | 7.1226 | 11.2840 | 38.30% |
| 2002 | 7.6528 | 7.9090 | 8.4489 | 6.3985 | 8.1591 | 2.31% |
| 2001 | 6.5108 | 5.9461 | 7.9877 | 5.4097 | 7.9745 | 33.75% |
| 2000 | 4.6147 | 4.4075 | 5.9623 | 3.3563 | 5.9623 | 35.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $13.871B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $220.159B | 25.82 |
| Boston Scientific (BSX) | United States | $157.028B | 37.51 |
| Stryker (SYK) | United States | $154.023B | 32.21 |
| EssilorLuxottica (ESLOY) | France | $136.572B | 0.00 |
| Medtronic (MDT) | Ireland | $119.200B | 16.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.384B | 25.33 |
| ResMed (RMD) | United States | $40.346B | 30.30 |
| GE HealthCare Technologies (GEHC) | United States | $35.536B | 16.87 |
| Agilent Technologies (A) | United States | $34.139B | 22.26 |
| Terumo (TRUMY) | Japan | $25.843B | 33.57 |
| Koninklijke Philips (PHG) | Netherlands | $25.190B | 17.68 |
| Insulet (PODD) | United States | $20.424B | 80.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.300B | 12.40 |
| Baxter (BAX) | United States | $14.995B | 11.19 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.189B | 25.02 |
| Lantheus Holdings (LNTH) | United States | $5.046B | 12.73 |
| Perrigo (PRGO) | Ireland | $3.908B | 9.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.799B | 16.97 |
| Haemonetics (HAE) | United States | $3.613B | 16.45 |
| Envista Holdings (NVST) | United States | $3.525B | 29.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.197B | 23.58 |
| LeMaitre Vascular (LMAT) | United States | $1.862B | 41.63 |
| QuidelOrtho (QDEL) | United States | $1.852B | 12.74 |
| AtriCure (ATRC) | United States | $1.559B | 0.00 |
| Acuren (TIC) | United States | $1.441B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.95 |
| AdaptHealth (AHCO) | United States | $1.274B | 12.93 |
| Phibro Animal Health (PAHC) | United States | $1.183B | 15.12 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.080B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.964B | 0.00 |
| InMode (INMD) | Israel | $0.930B | 9.38 |
| Kestra Medical Technologies (KMTS) | United States | $0.850B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.693B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Valneva SE (VALN) | France | $0.654B | 0.00 |
| Evolus (EOLS) | United States | $0.614B | 0.00 |
| Owens & Minor (OMI) | United States | $0.609B | 5.05 |
| CeriBell (CBLL) | United States | $0.547B | 0.00 |
| ZimVie (ZIMV) | United States | $0.521B | 23.70 |
| Surmodics (SRDX) | United States | $0.515B | 0.00 |
| SNDL (SNDL) | Canada | $0.398B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Capricor Therapeutics (CAPR) | United States | $0.322B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 80.67 |
| Cerus (CERS) | United States | $0.266B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 20.40 |
| Biote (BTMD) | United States | $0.236B | 6.65 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.230B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.227B | 0.00 |
| Omeros (OMER) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.65 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.86 |
| Quipt Home Medical (QIPT) | United States | $0.097B | 0.00 |
| Apyx Medical (APYX) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.082B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Nephros (NEPH) | United States | $0.038B | 51.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |